These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 7735126
1. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Ozer NK, Boscoboinik D, Azzi A. Biochem Mol Biol Int; 1995 Jan; 35(1):117-24. PubMed ID: 7735126 [Abstract] [Full Text] [Related]
2. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Bedel A, Nègre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, Maupas-Schwalm F. Circ Res; 2008 Sep 26; 103(7):694-701. PubMed ID: 18703780 [Abstract] [Full Text] [Related]
3. RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status. Azzi A, Boscoboinik D, Fazzio A, Marilley D, Maroni P, Ozer NK, Spycher S, Tasinato A. Z Ernahrungswiss; 1998 Sep 26; 37 Suppl 1():21-8. PubMed ID: 9558725 [Abstract] [Full Text] [Related]
4. Signalling functions of alpha-tocopherol in smooth muscle cells. Azzi A, Boscoboinik D, Clément S, Ozer NK, Ricciarelli R, Stocker A, Tasinato A, Sirikçi O. Int J Vitam Nutr Res; 1997 Sep 26; 67(5):343-9. PubMed ID: 9350476 [Abstract] [Full Text] [Related]
5. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Takahashi K, Takeya M, Sakashita N. Med Electron Microsc; 2002 Dec 26; 35(4):179-203. PubMed ID: 12658354 [Abstract] [Full Text] [Related]
6. Vitamin E: action, metabolism and perspectives. Herrera E, Barbas C. J Physiol Biochem; 2001 Mar 26; 57(2):43-56. PubMed ID: 11579997 [Abstract] [Full Text] [Related]
7. Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: Role of vitamin E. Kartal Ozer N, Negis Y, Aytan N. Biofactors; 2003 Mar 26; 19(1-2):63-70. PubMed ID: 14757978 [Abstract] [Full Text] [Related]
8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ, Guérin M, Bruckert E. Eur Heart J; 1998 Feb 26; 19 Suppl A():A24-30. PubMed ID: 9519339 [Abstract] [Full Text] [Related]
9. Vitamin E modulation of cardiovascular disease. Meydani M. Ann N Y Acad Sci; 2004 Dec 26; 1031():271-9. PubMed ID: 15753153 [Abstract] [Full Text] [Related]
10. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Boscoboinik D, Ozer NK, Moser U, Azzi A. Arch Biochem Biophys; 1995 Apr 01; 318(1):241-6. PubMed ID: 7726567 [Abstract] [Full Text] [Related]
11. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A. Circulation; 2008 Feb 05; 117(5):638-48. PubMed ID: 18212280 [Abstract] [Full Text] [Related]
12. [Vitamin E and cardiovascular prevention]. Léger C. Ann Biol Clin (Paris); 2000 Feb 05; 58(5):527-40. PubMed ID: 11022097 [Abstract] [Full Text] [Related]
13. [Vitamin E: metabolism and role in atherosclerosis]. Cogny A, Paul JL, Soni T, Atger V, Moatti N. Ann Biol Clin (Paris); 1994 Feb 05; 52(7-8):515-22. PubMed ID: 7840427 [Abstract] [Full Text] [Related]
14. [Antioxidant vitamins--significance for preventing cardiovascular diseases. Part 1. Oxidized low-density lipoproteins and atherosclerosis; antioxidant dietary supplementation--vitamin E]. Andreeva-Gateva P. Vutr Boles; 2000 Feb 05; 32(3):11-8. PubMed ID: 11688317 [Abstract] [Full Text] [Related]
15. [The role of low-density lipoprotein in the pathogenesis of atherosclerosis]. Zák A, Rublicová J, Skorepa J. Cas Lek Cesk; 1978 Oct 20; 117(42):1305-10. PubMed ID: 214233 [No Abstract] [Full Text] [Related]
16. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. Ozer NK, Palozza P, Boscoboinik D, Azzi A. FEBS Lett; 1993 May 17; 322(3):307-10. PubMed ID: 8486164 [Abstract] [Full Text] [Related]
18. Oxidized lipoproteins in atherosclerosis and thrombosis. Holvoet P, Collen D. FASEB J; 1994 Dec 17; 8(15):1279-84. PubMed ID: 8001740 [Abstract] [Full Text] [Related]
19. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Gey FK, Packer L, Azzi A. Biochim Biophys Acta; 1993 Mar 10; 1176(1-2):83-9. PubMed ID: 7680904 [Abstract] [Full Text] [Related]
20. What causes atherosclerosis? Kent S. Geriatrics; 1979 Feb 10; 34(2):85, 87, 89. PubMed ID: 216608 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]